Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
1st February 2013 - In draft guidance published today NICE (the National Institute for Health and Clinical Excellence) has said it is minded not to recommend dapagliflozin (Forxiga) in combination therapy for treating type 2 diabetes.
However, before it comes to a final decision, it is requesting further clarification and information from the manufacturers (Bristol-Myers Squibb and Astra Zeneca) ahead of a meeting in April.
http://www.webmd.boots.com/diabetes/news/20130201/new-diabetes-drug-rejected
However, before it comes to a final decision, it is requesting further clarification and information from the manufacturers (Bristol-Myers Squibb and Astra Zeneca) ahead of a meeting in April.
http://www.webmd.boots.com/diabetes/news/20130201/new-diabetes-drug-rejected
